# Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-outcomes-in-patients-with-hereditary-angioedema-prescribed/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John Anderson,Daniel Soteres,Raffi Tachdjian,Jennifer M. Mellor,Lucy Earl,Hannah Connolly,Kieran Wynne-Cattanach,Kellyn M. Moran,Krystal Sing,Bob G. Schultz,Salomé Juethner |
| Citations | 8 |
| DOI | 10.2500/aap.2024.45.240046 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.2500/aap.2024.45.240046 |
| OpenAlex ID | https://openalex.org/W4402587594 |
| PMID | 39293940 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Lucy Earl](https://scholariq.org/researchers/lucy-earl/)

## Paper primary topic

- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

## Paper topics

- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.